Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy

• Status: Completed
• Trial end date: 2018-12-30
• Target enrollment: 0
• Participant gender: Female

Summary

Research objective To compare effectiveness of oral Misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy Research hypothesis: Null hypothesis Effectiveness of oral misoprostal for cervical priming in premenopausal women underwent to diagnostic hysteroscopy is not different from placebo Alternative hypothesis: : Oral Misoprostal for cervical priming in Premenopausal women underwent to diagnostic hysteroscopy is better than placebo

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rajavithi Hospital
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

1. Premenopausal women

2. Patients have following indication for diagnosis hysteroscopy

• Abnormal uterine bleeding

• Unexplained infertility

• Recurrent pregnancy loss

• Chronic pelvic pain

• Late postpartum hemorrhage

3. Patients provided written informed consent

Exclusion Criteria:

1. Postmenopausal women

2. Patients who have contraindication for Misoprostal as following

• Allergic to Misoprostal

• Medical illnesses such as cardiovascular diseases, Asthma, Renal disease

3. Patients who have contraindication for Hysteroscopoy as following

• Pregnant women

• Pelvic inflammatory disease

• Infection at cervix and vagina

• Cervical cancer